Clinical Trial Results
Discover the data behind NADEssence™. Our commitment to transparency ensures you have access to the rigorous testing and proven efficacy of our NAD+ formulations.
Observed within the first 14 days of daily supplementation.
Across double-blind, placebo-controlled clinical studies.
Demonstrating a superior safety profile compared to alternatives.
Bioavailability & Absorption Rates
Our flagship study focused on the systemic absorption of NADEssence™ compared to traditional precursors. Results indicated a significantly higher retention rate in cellular tissue, suggesting our proprietary delivery mechanism bypasses common metabolic degradation.
- check 2.4x higher plasma concentration at 4 hours post-ingestion.
- check Sustained release profile extending benefit duration.
- check Confirmed intracellular uptake in leukocyte analysis.
Energy Levels Over 8 Weeks
Self-reported energy metrics (n=120)
Functional Impact: Energy & Focus
Beyond chemical markers, NADEssence™ aims to improve daily life. Participants in our double-blind study reported noticeable improvements in cognitive clarity and sustained physical energy, without the "crash" associated with stimulants.
"The clinical data for NADEssence represents a significant step forward in nutritional science. The stability and uptake profiles are unlike anything we have seen in previous NAD+ precursors."
Clinical FAQ
How were the trials conducted? expand_more
Is NADEssence FDA approved? expand_more
Where can I find the raw data? expand_more
Ready to ignite your cellular spark?
Join thousands of others experiencing the science-backed benefits of optimized NAD+ levels.